Risk assessment and HbA1c measurement in Norwegian community pharmacies to identify people with undiagnosed type 2 diabetes – A feasibility study
Open Access
- 23 February 2018
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 13 (2) , e0191316
Abstract
Determine the feasibility of using a diabetes risk assessment tool followed by HbA1c-measurement in a community-pharmacy setting in Norway. In this longitudinal study two pharmacists in each of three community pharmacies were trained to perform risk assessments, HbA1c-measurements and counselling. Pharmacy customers who were > 18 years old and could understand and speak Norwegian or English were recruited in the pharmacies during a two-months-period. Information about the service was presented in local newspapers, social media, leaflets and posters at the pharmacy. Customers wishing to participate contacted the pharmacy staff. Participants completed a validated diabetes risk test and a background questionnaire including a validated instrument for self-rated health. A HbA1c measurement was performed for individuals with a moderate to high risk of developing diabetes. If HbA1c ≥ 6.5% they were recommended to visit their general practitioner for follow-up. The pharmacies performed internal and external quality control of the HbA1c instrument. Of the 211 included participants 97 (46%) were > 50 years old. HbA1c was measured for the 47 participants (22%) with high risk. Thirty-two (15%) had HbA1c values < 5.7%, twelve (5.4%) had values between 5.7%—6.4%, and three (1.4%) had an HbA1c ≥ 6.5%. Two participants with HbA1 ≥ 6.5% were diagnosed with diabetes by their general practitioner. The third was lost to follow-up. Results from internal and external quality control for HbA1c were within set limits. The pharmacists were able to perform the risk assessment and measurement of HbA1c, and pharmacy customers were willing to participate. The HbA1c measurements fulfilled the requirements for analytical quality. Thus, it is feasible to implement this service in community pharmacies in Norway. In a large-scale study the inclusion criteria should be increased to 45 years in accordance with the population the risk test has been validated for.Keywords
This publication has 38 references indexed in Scilit:
- HbA1c testing in the community pharmacy: A new strategy to improve care for patients with diabetesCanadian Pharmacists Journal / Revue des Pharmaciens du Canada, 2012
- Health-Related Quality of Life Using the EuroQol 5D Questionnaire in Korean Patients with Type 2 DiabetesJournal of Korean Medical Science, 2012
- Emotional impact of screening: a systematic review and meta-analysisBMC Public Health, 2011
- The Leicester Risk Assessment score for detecting undiagnosed Type 2 diabetes and impaired glucose regulation for use in a multiethnic UK settingDiabetic Medicine, 2010
- Somali immigrant women and the American health care system: Discordant beliefs, divergent expectations, and silent worriesSocial Science & Medicine, 2010
- Standards of Medical Care in Diabetes—2010Diabetes Care, 2010
- International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of DiabetesDiabetes Care, 2009
- Psychological impact of screening for type 2 diabetes: controlled trial and comparative study embedded in the ADDITION (Cambridge) randomised controlled trialBMJ, 2007
- EuroQol©: health-related quality of life measurement. Valuations of health states by the general public in NorwayHealth Policy, 1991
- EuroQol - a new facility for the measurement of health-related quality of lifeHealth Policy, 1990